C. Betancur, M. Canton, D. Gully, G. Vela, D. Pélaprat et al., Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [ 3 H]SR 48692, in the guinea pig brain, J. Pharmacol. Exp. Ther, vol.273, pp.1450-1458, 1995.
URL : https://hal.archives-ouvertes.fr/inserm-00276482

C. Betancur, M. Azzi, and W. Rostène, Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy, Trends in Pharmacological Sciences, vol.18, issue.4, pp.372-386, 1997.
DOI : 10.1016/S0165-6147(97)90666-0
URL : https://hal.archives-ouvertes.fr/inserm-00276481

P. Chalon, N. Vita, M. Kaghad, M. Guillemot, J. Bonnin et al., Molecular cloning of a levocabastine-sensitive neurotensin binding site, FEBS Letters, vol.333, issue.2-3, pp.91-94, 1996.
DOI : 10.1016/0014-5793(96)00397-3

R. S. Chang, V. J. Lotti, T. B. Chen, and K. A. Kunkel, Characterization of the binding of A new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors, Mol. Pharmacol, vol.3364718, issue.30, pp.212-217, 1986.

R. S. Chang, T. B. Chen, M. G. Bock, R. M. Freidinger, R. Chen et al., Characterization of the binding of [ 3 H]L-365,260: A new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand, Mol. Pharmacol, vol.35, pp.803-808, 1989.

Y. Cheng and W. Prusoff, Relationship between the inhibition constant (K i ) and the concentration of inhibitor which causes 50% inhibition (IC 50 ) of an enzymatic reaction, Biochem. Pharmacol, vol.22, pp.3099-3108, 1973.

F. Z. Chung, C. D. Wang, P. C. Potter, J. C. Venter, and C. M. Fraser, Site-directed mutagenesis and continuous expression of human -adrenergic receptors, J. Biol. Chem, vol.263, pp.4052-4055, 1988.

I. Dubuc, J. Costentin, J. P. Terranova, M. C. Barnouin, P. Soubrié et al., The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes, British Journal of Pharmacology, vol.317, issue.2, pp.352-354, 1994.
DOI : 10.1111/j.1476-5381.1994.tb13077.x

P. C. Emson, M. Goedert, P. M. Horsfield, F. Rioux, . St et al., The Regional Distribution and Chromatographic Characterisation of Neurotensin-Like Immunoreactivity in the Rat Central Nervous System, Journal of Neurochemistry, vol.9, issue.4, pp.992-999, 1982.
DOI : 10.1016/0006-8993(78)90296-2

G. Gaudriault, N. Zsürger, and J. P. Vincent, Radiolabeled Ligands Specific for the G Protein-Coupled State of Neurotensin Receptors, Journal of Neurochemistry, vol.67, issue.6, pp.2590-2598, 1996.
DOI : 10.1046/j.1471-4159.1996.67062590.x

M. Goedert, K. Pittaway, B. J. Williams, and P. C. Emson, Specific binding of triatiated neurotensin to rat brain membranes: Characterization and regional distribution, Brain Research, vol.304, issue.1, pp.71-81, 1984.
DOI : 10.1016/0006-8993(84)90862-X

D. Gully, M. Canton, R. Boigegrain, F. Jeanjean, J. C. Molimard et al., Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor., Proc. Natl. Acad. Sci. USA 90, pp.65-69, 1993.
DOI : 10.1073/pnas.90.1.65

D. Gully, B. Labeeuw, R. Boigegrain, F. Oury-donat, A. Bachy et al., Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist, J. Pharmacol. Exp. Ther, vol.280, pp.802-812, 1997.

E. Hermans, J. N. Octave, and J. M. Maloteaux, Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist-induced internalization, Mol. Pharmacol, vol.49, pp.365-372, 1996.

J. Kasckow and C. B. Nemeroff, The neurobiology of neurotensin: focus on neurotensin-dopamine interactions, Regulatory Peptides, vol.36, issue.2, pp.153-164, 1991.
DOI : 10.1016/0167-0115(91)90053-J

P. Kitabgi, W. Rostène, M. Dussaillant, A. Schotte, P. M. Laduron et al., Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution, European Journal of Pharmacology, vol.140, issue.3, pp.285-293, 1987.
DOI : 10.1016/0014-2999(87)90285-8

C. Labbé-jullié, J. M. Botto, M. V. Mas, J. Chabry, J. Mazella et al., [ 3 H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: Characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor, Mol. Pharmacol, vol.47, pp.1050-1056, 1995.

F. Le, B. Cusak, and E. Richelson, The neurotensin receptor: is there more than one subtype?, Trends in Pharmacological Sciences, vol.17, issue.1, pp.1-3, 1996.
DOI : 10.1016/0165-6147(96)81561-6

S. Maeda, J. Lameh, W. G. Mallet, M. Philip, J. Ramachandran et al., Internalization of the Hm1 muscarinic cholinergic receptor involves the third cytoplasmic loop, FEBS Letters, vol.10, issue.2, pp.386-388, 1990.
DOI : 10.1016/0014-5793(90)81199-X

J. Mai, K. J. Triepel, and J. Metz, Neurotensin in the human brain, Neuroscience, vol.22, issue.2, pp.499-524, 1987.
DOI : 10.1016/0306-4522(87)90349-6

J. Mazella, C. Poustis, C. Labbé, F. Checler, P. Kitabgi et al., Monoiodo Trp11-neurotensin, a highly radioactive ligand of neurotensin receptors: Preparation, biological activity, and binding properties to rat brain synaptic membranes, J. Biol. Chem, vol.258, pp.3476-3481, 1983.

J. Mazella, J. M. Botto, E. Guillemare, T. Coppola, P. Sarret et al., Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain, J. Neurosci, vol.16, pp.5613-5620, 1996.

S. Mclean, A. H. Ganong, T. F. Seeger, D. K. Bryce, K. G. Pratt et al., Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist, Science, vol.251, issue.4992, pp.437-439, 1991.
DOI : 10.1126/science.1703324

E. Moyse, W. Rostène, M. Vial, K. Leonard, J. Mazella et al., Distribution of neurotensin binding sites in rat brain: A light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin, Neuroscience, vol.22, issue.2, pp.525-536, 1987.
DOI : 10.1016/0306-4522(87)90350-2

P. J. Munson and D. Rodbard, LIGAND: A versatile computerized approach for characterization of ligand-binding systems, Analytical Biochemistry, vol.107, issue.1, pp.220-239, 1980.
DOI : 10.1016/0003-2697(80)90515-1

A. Nicot, W. Rostène, and A. Bérod, Neurotensin receptor expression in the rat forebrain and midbrain: A combined analysis by in situ hybridization and receptor autoradiography, The Journal of Comparative Neurology, vol.586, issue.3, pp.407-419, 1994.
DOI : 10.1002/cne.903410310

T. A. Pugsley, H. C. Akunne, S. Z. Whetzel, S. Demattos, A. E. Corbin et al., Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists, Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists, pp.37-44, 1995.
DOI : 10.1016/0196-9781(94)00146-W

M. M. Rosenkilde, M. Cahir, U. Gether, S. A. Hjorth, and T. W. Schwartz, Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with nonpeptide antagonists but not substance P binding, J. Biol. Chem, vol.269, pp.28160-28164, 1994.

W. H. Rostène and M. J. Alexander, Neurotensin and Neuroendocrine Regulation, Frontiers in Neuroendocrinology, vol.18, issue.2, p.115, 1997.
DOI : 10.1006/frne.1996.0146

J. L. Sadoul, J. Mazella, S. Amar, P. Kitabgi, and J. P. Vincent, Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors, Biochemical and Biophysical Research Communications, vol.120, issue.3, pp.812-819, 1984.
DOI : 10.1016/S0006-291X(84)80179-5

A. Schotte, J. E. Leysen, and P. M. Laduron, Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.10, issue.4, pp.400-405, 1986.
DOI : 10.1007/BF00500016

A. Schotte, W. Rostène, and P. M. Laduron, Different Subcellular Localization of Neurotensin-Receptor and Neurotensin-Acceptor Sites in the Rat Brain Dopaminergic System, Journal of Neurochemistry, vol.2, issue.4, pp.1026-1031, 1988.
DOI : 10.1002/ddr.430080111

T. W. Schwartz, U. Gether, H. T. Schambye, and S. A. Hjorth, Molecular mechanism of action of nonpeptide ligands for peptide receptors, Curr. Pharm. Design, vol.1, pp.355-372, 1995.

R. Steinberg, P. Brun, M. Fournier, J. Souilhac, D. Rodier et al., SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission, Neuroscience, vol.59, issue.4, pp.921-929, 1994.
DOI : 10.1016/0306-4522(94)90295-X

R. A. Stockbroekx, M. G. Luyckx, J. M. Willems, M. A. Janssen, J. O. Bracke et al., Levocabastine (R 50547): The prototype of a chemical series of compounds with specific H1-antihistaminic activity, Drug Development Research, vol.251, issue.1-4, pp.87-93, 1986.
DOI : 10.1002/ddr.430080111

V. D. Talkad, K. P. Fortune, D. A. Pollo, G. N. Shah, S. A. Wank et al., Direct demonstration of three different states of the pancreatic cholecystokinin receptor., Proc. Natl. Acad. Sci. USA 91, pp.1868-1872, 1994.
DOI : 10.1073/pnas.91.5.1868

K. Tanaka, M. Masu, and S. Nakanishi, Structure and functional expression of the cloned rat neurotensin receptor, Neuron, vol.4, issue.6, pp.847-854, 1990.
DOI : 10.1016/0896-6273(90)90137-5

M. Teitler, S. Leonhardt, E. L. Weisberg, and B. J. Hoffman, 4-[ 125 I]iodo-(2,5- dimethoxy)phenylisopropylamine and [ 3 H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: Evidence for multiple states and not multiple 5HT2 receptor subtypes, Mol. Pharmacol, vol.38, pp.594-598, 1990.

J. P. Vincent, Neurotensin receptors: Binding properties, transduction pathways, and structure, Cellular and Molecular Neurobiology, vol.639, issue.5, pp.501-512, 1995.
DOI : 10.1007/BF02071313

N. Vita, P. Laurent, S. Leport, P. Chalon, X. Dumont et al., Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor, FEBS Letters, vol.140, issue.1-2, pp.139-142, 1993.
DOI : 10.1016/0014-5793(93)81509-X

M. Waelbroeck, P. Robberecht, P. Chatelain, C. , and J. , Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high-and low-affinity binding sites, Mol. Pharmacol, vol.21, pp.581-588, 1982.

M. Yamada, M. Yamada, M. A. Watson, and E. Richelson, Deletion of the putative third intracellular loop of the rat neurotensin receptor abolishes phosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells, Mol. Pharmacol, vol.46, pp.470-476, 1994.